Dose-dependent Effect of Fentanyl on Cough Attenuation During Emergence From General Anaesthesia

Sponsor
Yonsei University (Other)
Overall Status
Completed
CT.gov ID
NCT01308320
Collaborator
(none)
42
1
4
4.9
8.5

Study Details

Study Description

Brief Summary

Fentanyl is expected to suppress tracheal tube-induced cough during emergence from general anaesthesia through binding to its receptors in the brainstem. However, it has not been proven if fentanyl has a complication-free, dose-dependent effect on cough suppression during emergence from sevoflurane anaesthesia. The purpose of this study is to evaluate the relationship between fentanyl doses and cough suppression during emergence from sevoflurane anaesthesia.

Condition or Disease Intervention/Treatment Phase
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
42 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Supportive Care
Official Title:
Dose-dependent Effect of Fentanyl on Cough Attenuation During Emergence From General Anaesthesia
Study Start Date :
Feb 1, 2010
Actual Primary Completion Date :
Jul 1, 2010
Actual Study Completion Date :
Jul 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: saline

control group

Drug: saline
According to the enrolled group, certain dose of saline is intravenously administered by bolus just after sevoflurane discontinuation.

Active Comparator: F1 group

F1 group : fentanyl 1 mcg/kg

Drug: fentanyl citrate
According to the enrolled group, certain dose of fentanyl is intravenously administered by bolus just after sevoflurane discontinuation.

Active Comparator: F1.5 group

F1.5 group : fentanyl 1.5 mcg/kg

Drug: fentanyl citrate
According to the enrolled group, certain dose of fentanyl is intravenously administered by bolus just after sevoflurane discontinuation.

Active Comparator: F2 group

F2 group : fentanyl 2 mcg/kg

Drug: fentanyl citrate
According to the enrolled group, certain dose of fentanyl is intravenously administered by bolus just after sevoflurane discontinuation.

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 59 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • the patients undergoing general anaesthesia for elective thyroidectomy due to thyroid neoplasm.

    • ASA I-II.

    • 20-59 years old.

    • female only.

    Exclusion Criteria:
    • signs of difficult intubation.

    • risks for perioperative pulmonary aspiration.

    • history of chronic respiratory disease.

    • recent upper respiratory track infection.

    • previous and recent smoking history

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Severance Hospital Seoul Korea, Republic of 120-752

    Sponsors and Collaborators

    • Yonsei University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01308320
    Other Study ID Numbers:
    • 4-2009-0111
    First Posted:
    Mar 4, 2011
    Last Update Posted:
    Mar 4, 2011
    Last Verified:
    Mar 1, 2011
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 4, 2011